Back Pain News and Research

Latest Back Pain News and Research

Mass. adopts stricter rules, penalties for compounding pharmacies

The emergency regulations will allow the state to monitor contamination and the volume of medicines being made.

3 Nov 2012

ACP urges use of performance measures targeting 'low-value services' to reduce overuse, misuse of these approaches

The American College of Physicians released a position paper Monday pressing for "valid, evidence-based measures" as a means of raising physician awareness and changing clinician behavior.

31 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

$Epidural steroid injection may increase risk of bone fractures$

Epidural steroid injection may increase risk of bone fractures

Patients treated with an epidural steroid injection for back pain relief are at increased risk of bone fractures in the spine, according to a Henry Ford Hospital study.

26 Oct 2012

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed’s Freedom® Lumbar and Freedom® Cervical Discs.

24 Oct 2012

Neurophysiologic mechanism may underpin manual therapy effects

Non-thrust manual therapy may reduce chronic low-back pain by attenuating side-to-side differences in the stretch reflex amplitude of the erector spinae muscles, study findings suggest.

24 Oct 2012

Viewpoints: LA Times endorses Obama; Romney, Ryan 'obfuscating their plans for Medicare, Medicaid;' Obama's health law polarizes the country

The outcome of the presidential election will determine which of two opposing paths the nation will follow on health care for all Americans. If voters re-elect President Obama, he will protect the health care reforms.

23 Oct 2012

Viewpoints: 'Scrappy' debate offered little new on entitlement programs; Staring down the fiscal cliff

President Obama and Mitt Romney faced off Tuesday night in a scrappy, at times downright nasty town-hall debate that featured a feistier, more focused Obama than was seen in their first encounter and that broadened the discussion to social issues such as immigration, contraceptive coverage and gun control. ... In the end, on the domestic front, the debate performance of both has been about as disappointing as their dodging on the campaign trail.

19 Oct 2012

Kids encouraged to Stand Up for their health and be active

Children and adolescents are accumulating up to eight hours of sitting on a daily basis, research to be presented at Australia’s paramount sports medicine, sports science, sports injury prevention and physical activity promotion conference, be active2012 will show (October 31- November 3, Sydney).

16 Oct 2012

Thrust techniques do not outweigh nonthrust for low-back pain

Early use of thrust manipulation does not offer improved outcomes and a quicker recovery from low-back pain compared with nonthrust techniques, US study findings suggest.

16 Oct 2012

Merck announces results from odanacatib Phase II trial on post-menopausal osteoporosis

Merck, known as MSD outside the United States and Canada, today announced results from a Phase II trial for odanacatib, an investigational cathepsin K (cat-K) inhibitor in development for the treatment of osteoporosis in post-menopausal women.

15 Oct 2012

Top-line results from Pfizer’s ALO-02 Phase 3 study on chronic non-cancer pain

Pfizer Inc. announced top-line results today from a Phase 3 open-label long-term safety study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic, non-cancer pain.

12 Oct 2012

Nearly all groups of patients with spinal stenosis do better with surgery

Nearly all groups of patients with spinal stenosis—but not smokers—do better with surgery than with nonsurgical treatment, reports a study in the October 1 issue of Spine.

10 Oct 2012

Mayo researchers discover new therapy for patients with neuromyelitis optica

Mayo Clinic researchers have identified a new therapy for patients with neuromyelitis optica that appears to stop inflammation of the eye nerves and spinal cord. NMO is a debilitating central nervous system disorder that is often misdiagnosed as multiple sclerosis (MS).

10 Oct 2012

HVLA manipulation comes out top for low-back pain

Spinal high-velocity-low-amplitude manipulation for the treatment of nonspecific low-back pain has shown to be superior to a nonsteroidal anti-inflammatory drug, researchers report.

9 Oct 2012

Simple questionnaire helps predict prognosis in back pain patients

The Örebro Musculoskeletal Pain Questionnaire and a prognostic assessment may help manual therapists identify patients with low-back pain who are at risk for persistent problems following manual therapy, research indicates.

2 Oct 2012

New evidence-based guidelines for management of acute low back pain

According to an article in the October issue of the Journal of the American College of Radiology, radiologists at Emory University Hospital, in Atlanta, and Georgia Health Sciences University, in Augusta, Ga., have developed evidence-based guidelines to assist physicians with the process of managing patients with acute low back pain.

1 Oct 2012

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis, Inc. today announced interim data from 51 patients with metastatic castration-resistant prostate cancer (CRPC) and bone metastases receiving a 40 mg daily dose of cabozantinib in an ongoing non-randomized expansion (NRE) cohort of a phase 2 randomized discontinuation trial.

1 Oct 2012

Nearly 20% of people develop PTSD symptoms after low back fusion surgery

Nearly 20 percent of people who underwent low back fusion surgery developed post-traumatic stress disorder symptoms associated with that surgery, according to a recent Oregon Health & Science University study published in the journal Spine.

29 Sep 2012

Link between work-family conflict and musculoskeletal pain among nurses

Nurses and other hospital workers, especially those who work long hours or the night shift, often report trying to juggle the demands of the job and family obligations. A study out today by The George Washington University School of Public Health and Health Services (SPHHS) suggests that the higher the work-family conflict the greater the risk that health care workers will suffer from neck and other types of musculoskeletal pain.

28 Sep 2012